The MEDALIST trial was a phase 3 study with patients with ESA-refractory, low-risk MDS who require transfusions. In this ...
Faron Pharmaceuticals Ltd (AIM:FARN)(First North:FARON) announces a correction to the company announcement of its half-year financial results 1 January - 30 June 2025, originally published on August ...
Curis, Inc. (NASDAQ: CRIS), a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, ...
Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) - Significant clinical and financial milestones achieved in first half of 2025 TURKU, FI / ACCESS Newswire / September 12, 2025 / Faron Pharmaceuticals Ltd ...
OrthoWest has announced the expansion of Switchboard, MD’s physician-built AI platform across its orthopedic enterprise, bringing its advanced Contact Center solution to enable smarter call handling ...
KUALA LUMPUR, Sept 23 (Reuters) - The Malaysian Court of Appeal has overturned a High Court injunction that allowed Shell MDS (Malaysia) to halt its monthly gas payments to national energy firm ...
While executives debate AI strategy in boardrooms, the real disruption is already happening on the frontlines. From automated scheduling to AI-assisted diagnostics to customer service chatbots, ...
In the first-line treatment of higher-risk myelodysplastic syndromes (MDS), the combination of venetoclax with azacitidine fell short of the primary endpoint of a reduction in mortality compared with ...
September 29, 2025: We removed an expired code and checked for new GF2 codes, of which there are currently none. What are the latest Girls Frontline 2 codes? GF2 Exilium is different from anything you ...
Ben Ames has spent 30 years as a journalist since starting out as a reporter for daily newspapers in Pennsylvania and Massachusetts. He has focused on business and technology reporting since 1999 for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results